Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 4Thoracic 1NET 1Head & Neck 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Capecitabine 47Radiotherapy 46Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
68Ga-FAPI × Tumor-Agnostic × Clear all
NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Zhongnan Hospital

Phase NA Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT04023240 2024-08-12

68-Ga-FAPI PET Imaging in Malignancy

Stanford University

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT05506566 2023-09-21

68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies

First Affiliated Hospital of Fujian Medical University

Phase 1/2 Unknown
50 enrolled
Tumor-Agnostic

Neoplasms

NCT05691894 2023-01-20

Tracer Targeting FAP PET Imaging in Patients

Affiliated Hospital of Jiangnan University

Phase EARLY_PHASE1 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡